Cerebrospinal Fluid Biogenic Amines in Obsessive Compulsive Disorder, Tourette's Syndrome, and Healthy Controls
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
To examine the role of noradrenergic, dopaminergic, and serotonergic mechanisms in the pathobiology of obsessive compulsive disorder (OCD) and Tourette's syndrome (TS), concentrations of tyrosine (TYR), norepinephrine (NE), 3-methoxy-4-hydroxyphenylethylene glycol (MHPG), homovanillic acid (HVA), tryptophan (TRP), and 5-hydroxyindoleacetic acid (5-HIAA) were measured in the lumbar cerebrospinal fluid (CSF) of 39 medication-free OCD patients, 33 medication-free TS patients, and 44 healthy volunteers. CSF TYR concentrations were reduced (p < .05) in the OCD patients compared to the healthy subjects. CSF NE in TS patients was 55% higher than in healthy controls (p < .001) and 35% higher than in OCD patients (p < .001). After covarying for height, CSF HVA levels were reduced (p < .05) in the OCD group compared to TS patients but not compared to the normal volunteers. No mean differences in CSF MHPG, TRP, and 5-HIAA were observed in this study across the three groups. The CSF NE data support the hypothesis that noradrenergic mechanisms are involved in the pathobiology of TS. Alterations in the balance of noradrenergic, dopaminergic, and serotonergic systems are likely involved in the pathobiology of OCD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“plasma catecholamines and metabolites are not changed in OCD (Benkelfat et al. 1991) concurring with no change in cerebrospinal fluid (CSF) concentrations of biogenic amines and metabolites (Leckman et al. 1995), supersensitive beta-adrenergic receptors are measured by detecting adenylate cyclase activity in platelets of OCD patients (Marazziti et al. 2009).”
From The neurobiological link between OCD and ADHD (2014) · cites this paper as Leckman et al. 1995
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Self-citationThe Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Self-citationThe yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
Self-citationBest Estimate of Lifetime Psychiatric Diagnosis: A Methodological Study
Leckman, J. F. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290080001001 · Cited by 1,425
Self-citationClinical characteristics and family history in DSM-III obsessive- compulsive disorder
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.3.317 · Cited by 668
McDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
Self-citationThe Inheritance of Gilles de la Tourette's Syndrome and Associated Behaviors
Pauls, D. L., & Leckman, J. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151604 · Cited by 493
Self-citationToward a Neuroanatomy of Obsessive-Compulsive Disorder
Insel, T. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090067011 · Cited by 458
Cited by
Leckman, J. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11526-1 · Cited by 685
Self-citationCourse of Tic Severity in Tourette Syndrome: The First Two Decades
Leckman, J. F., Zhang, H., Vitale, A., Lahnin, F., Lynch, K., Bondi, C., Kim, Y.-S., & Peterson, B. S. (1998) · Pediatrics · doi:10.1542/peds.102.1.14 · Cited by 685
Self-citationStein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Glutamatergic Dysfunction in OCD
Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300733 · Cited by 344
“To our knowledge, this is the first published report investigating CSF glutamate levels in OCD patients, although there have been previous studies investigating various biogenic amines in CSF in OCD patients (Thoren et al, 1980; Insel et al, 1985; Swedo et al, 1992; Leckman et al, 1995).”
ResultTryptophan in health and disease
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 294
Obsessive-compulsive disorder phenotypes: implications for genetic studies
Miguel, E. C., Leckman, J. F., Rauch, S., do Rosario-Campos, M. C., Hounie, A. G., Mercadante, M. T., Chacon, P., & Pauls, D. L. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001617 · Cited by 282
Self-citationThe neurobiology of repetitive behavior: …and men
Langen, M., Durston, S., Kas, M. J. H., van Engeland, H., & Staal, W. G. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.005 · Cited by 263
Repetitive behaviors in autistic disorder.
Militerni, R., Bravaccio, C., Falco, C., Fico, C., & Palermo, M. T. (2002) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-002-0279-x · Cited by 282
“It is likely that the neural structures and chemistry underlying the production of behaviors common in other conditions [5, 18, 26, 30 , 51] are the same ones implicated in autistic subjects.”
BackgroundRegulation of anxiety during the postpartum period
Lonstein, J. S. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.05.002 · Cited by 231
“are often associated with increased peripheral and central measures of noradrenergic activity [172,236,252,254,354, 359,373,384,479].”
BackgroundSinger, H. S., & Minzer, K. (2003) · Brain and Development · doi:10.1016/s0387-7604(03)90012-x · Cited by 213
Neurobiological Substrates of Tourette's Disorder
Leckman, J. F., Bloch, M. H., Smith, M. E., Larabi, D., & Hampson, M. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0118 · Cited by 198
“For example, a series of adult TD patients were found to have elevated levels of cerebrospinal fluid (CSF) norepinephrine (Leckman et al. 1995) and to have excreted high levels of urinary norepinephrine in response to the stress associated with a lumbar puncture (Chappell et al. 1994).”
Self-citationPathogenesis of Tourette's Syndrome
Leckman, J. F., Peterson, B. S., Anderson, G. M., Arnsten, A. F. T., Pauls, D. L., & Cohen, D. J. (1997) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1997.tb01508.x · Cited by 170
Self-citationEnvironmental factors in Tourette syndrome
Hoekstra, P. J., Dietrich, A., Edwards, M. J., Elamin, I., & Martino, D. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.010 · Cited by 162
Neurobiology of Obsessive-Compulsive Disorder:Serotonin and Beyond
Westenberg, H. G. M., Fineberg, N. A., & Denys, D. (2007) · CNS Spectrums · doi:10.1017/s1092852900002479 · Cited by 148
Mansueto, C. S., & Keuler, D. J. (2005) · Behavior Modification · doi:10.1177/0145445505279261 · Cited by 132
The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies
Kalk, N., Nutt, D., & Lingford-Hughes, A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367448 · Cited by 123
“A single such study of social phobia showed no difference in plasma noradrenaline relative to healthy controls at baseline or in response to an orthostatic challenge (Leckman et al., 1995; Stein et al., 1992).”
BackgroundCarpenter, L. L., Moreno, F. A., Kling, M. A., Anderson, G. M., Regenold, W. T., Labiner, D. M., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.025 · Cited by 123
Self-citationDecreased sleep quality and increased sleep related movements in patients with Tourette's syndrome
Cohrs, S., Rasch, T., Altmeyer, S., Kinkelbur, J., Kostanecka, T., Rothenberger, A., Rüther, E., & Hajak, G. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.2.192 · Cited by 129
“The two aminergic transmitters serotonin and noradrenaline (norepinephrine) have been found to be involved in sleep regulation as well as pathophysiology of Tourette's syndrome.”
BackgroundNEUROBIOLOGY OF TOURETTE SYNDROME
Singer, H. S. (1997) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70318-2 · Cited by 119
Grice, D. E., Leckman, J. F., Pauls, D. L., Kurlan, R., Kídd, K. K., PAKSTIS, A. J., Chang, F. M., Buxbaum, J. D., Cohen, D. J., & Gelernter, J. E. (1996) · PubMed · Cited by 133
Self-citationRole of serotonin in obsessive-compulsive disorder
Baumgarten, H. G., & Grozdanovic, Z. (1998) · The British Journal of Psychiatry · doi:10.1192/s0007125000297857 · Cited by 117
The neurobiological link between OCD and ADHD
Brem, S., Grünblatt, E., Drechsler, R., Riederer, P., & Walitza, S. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0146-x · Cited by 109
“1991) concurring with no change in cerebrospinal fluid (CSF) concentrations of biogenic amines and metabolites (Leckman et al. 1995), supersensitive beta-adrenergic receptors are measured by detecting adenylate cyclase activity in platelets of OCD patients (Marazziti et al.”
BackgroundFerrão, Y. A., Miguel, E., & Stein, D. J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.008 · Cited by 107
“Compared with patients with OCD alone, OCD patients with tics usually presentwith anearlier age of onset (Leckmanet al.,1995;Miguel et al., 1997; Rosario-Campos et al., 2001; Diniz et al., 2004; Diniz et al., 2005); and are more frequently males (Holzer et al., 1994; Leckman et al.,1995).”
ResultRepetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences?
Cath, D. C., Spinhoven, P., Hoogduin, C. A. L., Landman, A. D., van Woerkom, T. C. A. M., van de Wetering, B. J. M., Roos, R. A. C., & Rooijmans, H. G. M. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00219-0 · Cited by 121
Obsessive-Compulsive Disorder in Children and Adolescents: A Review of the Past 10 Years
March, J. S., & Leonard, H. L. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199610000-00012 · Cited by 121
Langley, A. K., Lewin, A. B., Bergman, R. L., Lee, J. C., & Piacentini, J. C. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0101-0 · Cited by 96
“tionship between OCD, ADHD, and tic disorders [20, 33], the highest rate of comorbid tic disorder was found in”
BackgroundNeurobiology and neuroimmunology of Tourette's syndrome: an update
Korf, J., Anderson, G. M., Hoekstra, P. J., Limburg, P. C., Kallenberg, C. G. M., & Minderaa, R. B. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3320-4 · Cited by 61
Self-citationChappell, P., Leckman, J., Goodman, W., Bissette, G., Pauls, D., Anderson, G., Riddle, M., Scahill, L., McDougle, C., & Cohen, D. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00221-9 · Cited by 85
Self-citationLeckman, J. F., Peterson, B. S., Pauls, D. L., & Cohen, D. J. (1997) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70348-8 · Cited by 103
Self-citationTourette syndrome and obsessive compulsive disorder: Compulsivity along the continuum
Eddy, C. M., & Cavanna, A. E. (2014) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2014.04.003 · Cited by 84
STEEVES, T., & FOX, S. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00924-2 · Cited by 79
Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome
Haugbøl, S., Pinborg, L. H., Regeur, L., Hansen, E. S., Bolwig, T. G., Nielsen, F. Å., Svarer, C., Skovgaard, L. T., & Knudsen, G. M. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006559 · Cited by 75
Pharmacological animal models of Tourette syndrome
Bronfeld, M., Israelashvili, M., & Bar‐Gad, I. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.010 · Cited by 73
Marin‐Valencia, I., Serrano, M., Ormazábal, A., Pérez‐Dueñas, B., García‐Cazorla, À., Campistol, J., & Artuch, R. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.08.077 · Cited by 70
The Modulating Role of Stress in the Onset and Course of Tourette’s Syndrome: A Review
Buse, J., Kirschbaum, C., Leckman, J. F., Münchau, A. M., & Roessner, V. (2014) · Behavior Modification · doi:10.1177/0145445514522056 · Cited by 76
“With regard to this mechanism, the increased activation of HPA axis observed in TS patients might possibly also be considered to be a consequence of elevated inflammatory response, for example, to GAS infection.”
BackgroundSelf-citationHesse, S., Stengler, K., Regenthal, R., Patt, M., Becker, G.-A., Franke, A., Knüpfer, H., Meyer, P. M., Luthardt, J., Jahn, I., et al. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001604 · Cited by 65
Is Tourette's syndrome an autoimmune disease?
Hoekstra, P. J., Kallenberg, C. G. M., Korf, J., & Minderaa, R. B. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000972 · Cited by 62
Genetic Susceptibility and Neurotransmitters in Tourette Syndrome
Paschou, P., Fernandez, T. V., Sharp, F. R., Heiman, G. A., & Hoekstra, P. J. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00006-8 · Cited by 70
Neuroendocrine Aspects of Tourette Syndrome
Martino, D., Macerollo, A., & Leckman, J. F. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00009-3 · Cited by 62
Self-citationMoya, P. R., Wendland, J. R., Rubenstein, L. M., Timpano, K. R., Heiman, G. A., Tischfield, J. A., King, R. A., Andrews, A. M., Ramamoorthy, S., McMahon, F. J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25460 · Cited by 58
“By increasing serotonin clearance, both higher expressing SLC6A4 alleles and the gain-of-function SERT I425V variant would confer an hyposerotonergic status, a condition that was suggested in some studies beginning 2 decades ago(44,45) (however, see Leckman et al.(34)).”
BackgroundWhat is the Optimal Way to Subdivide Obsessive-Compulsive Disorder?
de Mathis, M. A., Diniz, J. B., do Rosário, M. C., Torres, A. R., Hoexter, M., Hasler, G., & Miguel, E. C. (2006) · CNS Spectrums · doi:10.1017/s1092852900014899 · Cited by 60
Cath, D. C., Spinhoven, P., van Woerkom, T. C. A. M., van de Wetering, B. J. M., Hoogduin, C. A. L., Landman, A. D., Roos, R. A. C., & Rooijmans, H. G. M. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200104000-00003 · Cited by 60
Animal models of tic disorders: A translational perspective
Godar, S. C., Mosher, L. J., Giovanni, G. D., & Bortolato, M. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.09.008 · Cited by 55
“…based on serotonin and norepinephrine stimulation Evidence on the involvement of serotonin and norepinephrine in TS is inconclusive (Singer et al., 1982, 1990; Baker et al., 1990; Bornstein and Baker, 1990; Leckman et al., 1995; Heinz et al., 1998; Muller-Vahl et al., 2005; Wong et al., 2008).”
BackgroundDiscrete Forebrain Neuronal Networks Supporting Noradrenergic Regulation of Sensorimotor Gating
Alsene, K. M., Rajbhandari, A. K., Ramaker, M. J., & Bakshi, V. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.238 · Cited by 56
Obsessive-Compulsive Spectrum Disorders: A Review of the Evidence-Based Treatments
Ravindran, A. V., da Silva, T. L., Ravindran, L. N., Richter, M. A., & Rector, N. A. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400507 · Cited by 58
Pharmacotherapeutic Strategies and New Targets in OCD
Pittenger, C. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_204 · Cited by 58
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder
Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Burbaud, P., Tignol, J., & Bioulac, B. H. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a789 · Cited by 51
“However, these results have not been confirmed in other investigations that reported normal CSF concentrations of 5-HIAA (Thoren et al 1980; Leckman et al 1995).”
Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome
Behen, M. E., Chugani, H. T., Juhász, C., Helder, E. J., Ho, A., Maqbool, M., Rothermel, R. D., Perry, J., & Muzik, O. (2007) · Movement Disorders · doi:10.1002/mds.21712 · Cited by 53
Sallee, F. R., Richman, H., BEACH, K., Sethuraman, G., & Nesbitt, L. A. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199612000-00017 · Cited by 55
Bayle, C., Siri, N., Poinsot, V., Treilhou, M., Caussé, E., & Couderc, F. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00939-7 · Cited by 52
Vythilingam, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4138 · Cited by 51
“Concentrations of plasma and CSF NE and other metabolites [homovanillic acid and 3-methoxy-4-hydroxyphenylglycol (MHPG)] were measured using high performance liquid chromatography ( 47 ).”
MethodSelf-citation5HT2C CYS23/SER23 polymorphism is not associated with obsessive–compulsive disorder
Cavallini, M. C., Bella, D. D., Pasquale, L., Henin, M., & Bellodi, L. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(97)00151-0 · Cited by 52
Serum folate and homocysteine levels in patients with obsessive‐compulsive disorder
Atmaca, M., Tezcan, E., Kuloğlu, M., KIRTAS, O., & Üstündağ, B. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01425.x · Cited by 51
“Some studies reported high levels of epinephrine, 5HT and HVA,(23) others reported low levels.(24) It may be that homocysteine is a very good index of folic acid status of the patient or that it has, a yet unspecified interaction with the CNS that produces depression.”
BackgroundNeurobiology of Childhood Obsessive-Compulsive Disorder
Fitzgerald, K. D., MacMaster, F. P., Paulson, L. A. D., & Rosenberg, D. R. (1999) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30168-8 · Cited by 54
Systematic review of co-occurring OCD and TD: Evidence for a tic-related OCD subtype?
Kloft, L., Steinel, T., & Kathmann, N. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.021 · Cited by 47
“Two studies suggest serotonergic hyperactivity of OCD+TD compared to OCD by showing increased capacity of 5-HT precursor tryptophan and a higher concentration of 5-HIAA (Leckman et al., 1995; Leonard et al., 1993).”
Immune Mechanisms in Pediatric Neuropsychiatric Disorders: Tourette’s Syndrome, OCD, and PANDAS
Trifiletti, R. R., & Packard, M. (1999) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30152-4 · Cited by 52
Brambilla, F., Bellodi, L., Perna, G., Arancio, C., & Bertani, A. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00549-5 · Cited by 46
Neurobiological issues in Tourette syndrome
Singer, H. S. (1994) · Brain and Development · doi:10.1016/0387-7604(94)90122-8 · Cited by 45
Depression in Tourette syndrome: A controlled and comparison study
Piedad, J. C. P., & Cavanna, A. E. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.030 · Cited by 47
“Previous studies employing a variety of clinical rating scales for depression in child, adolescent and some adult cohorts have consistently found higher scores in patients with TS compared to healthy controls [31-37].”
BackgroundThe genetics of Tourette disorder
State, M. W. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.007 · Cited by 40
Obsessive-Compulsive and Tic-Related Disorders
Franklin, M. E., Harrison, J. P., & Benavides, K. L. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.05.008 · Cited by 41
The Neurochemistry of Tourette Syndrome
Singer, H. S. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796267.003.0013 · Cited by 44
Hayslett, R. L., & Tizabi, Y. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.010 · Cited by 40
Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional Drugs
Bhattacharyya, S., & Chakraborty, K. (2007) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488907779561727 · Cited by 39
“There is a growing body of literature from imaging [12-16], cerebrospinal fluid (CSF) [6,17,18] and pharmacological challenge stu-dies [19] supporting the serotonergic dysfunction hypothesis in OCD.”
BackgroundInfluentialAlsene, K. M., & Bakshi, V. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.47 · Cited by 39
Moreno, M., Gutiérrez-Ferre, V. E., Ruedas, L., Campa, L., Sunol, C. E., & Flores, P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2575-y · Cited by 40
“Moreover, adult patients with OCD and psychosis also reported high levels of NE, 5-HT and its metabolite in urine and in cerebrospinal fluid samples (Insel et al. 1985; Leckman et al. 1995; Oades et al. 1994).”
Development of infrared optical sensor for selective detection of tyrosine in biological fluids
Huang, G. G., & Yang, J. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.11.001 · Cited by 40
Fan, S., Cath, D. C., van den Heuvel, O. A., van der Werf, Y. D., Schöls, C., Veltman, D. J., & Pouwels, P. J. W. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.12.007 · Cited by 36
Tourette disorder and other tic disorders
Fernandez, T. V., State, M. W., & Pittenger, C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00023-3 · Cited by 36
FUTURE THERAPIES OF TOURETTE SYNDROME
Chappell, P. B., Scahill, L. D., & Leckman, J. F. (1997) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70324-8 · Cited by 34
Self-citationMarcus, D., & Kurlan, R. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70043-8 · Cited by 34
THERMAL SENSITIVITY IN TOURETTE SYNDROME: PRELIMINARY REPORT
Scahill, L. D., Lombroso, P. J., Mack, G. W., van Wattum, P. J., Zhang, H., Vitale, A., & Leckman, J. F. (2001) · Perceptual and Motor Skills · doi:10.2466/pms.2001.92.2.419 · Cited by 34
Self-citationBerney, A., Leyton, M., Gravel, P., Sibon, I., Sookman, D., Rosa‐Neto, P., Dikšić, M., Nakai, A., Pinard, G., Todorov, C., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.16 · Cited by 35
Randomized Controlled Trial of Probiotic PS128 in Children with Tourette Syndrome
Wu, C.-C., Wong, L., Hsu, C., Yang, C.-W., Tsai, Y.-C., Cheng, F.-S., Hu, H., & Lee, W. (2021) · Nutrients · doi:10.3390/nu13113698 · Cited by 33
“systems reflected by the reduced caudate volume over time [3], hyperresponsive spikedependent dopamine release following stimulation [4], reduction in cerebrospinal fluid of 5-hydroxyindoleacetic acid [5], and gene polymorphism [6,7].”
BackgroundInfluentialGrimaldi, B. L. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1447 · Cited by 33
Acute changes in Cerebrospinal Fluid 5-HIAA following Oral Paroxetine Challenge in Healthy Humans
Carpenter, L. L., Anderson, G. M., Siniscalchi, J. M., Chappell, P. B., & Price, L. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300025 · Cited by 32
“The concentration of CSF norepinephrine (NE) was determined by HPLC with aperometric detection after alumina extraction of 0.5 ml of CSF; the interassay CV of this method is 7.5% (Anderson et al, 1988; Leckman et al, 1995).”
MethodSelf-citationADVANCES IN THE NEUROBIOLOGY OF OBSESSIVE-COMPULSIVE DISORDER
Stein, D. J. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70180-5 · Cited by 47
Bortolato, M., Frau, R., Godar, S. C., Mosher, L. J., Paba, S., Marrosu, F., & Devoto, P. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12066 · Cited by 34
Kaye, W. H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48204.x · Cited by 34
Tic or Compulsion? It's Tourettic OCD
Mansueto, C. S., & Keuler, D. J. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.3.foc361 · Cited by 28
D8/17 Monoclonal Antibody: An Unclear Neuropsychiatric Marker
Morer, Á., Viñas, O., Lázaro, L., Bosch, J., Toro, J., & Castro, J. (2005) · Behavioural Neurology · doi:10.1155/2005/795343 · Cited by 28
Abnormal topography of EEG microstates in Gilles de la Tourette syndrome
Stevens, A., Günther, W., Lutzenberger, W., Bartels, M., & Müller, N. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189024 · Cited by 30
Chu, Q., Guan, Y., Geng, C.-H., & Ye, J. (2006) · Analytical Letters · doi:10.1080/00032710600611129 · Cited by 25
“1997), obsessive compulsive disorders (Leckman et al. 1995), or schizophrenia (Garbutt et al.”
BackgroundNeuropathology in Tourette Syndrome
Swerdlow, N. R., & Young, A. B. (1999) · CNS Spectrums · doi:10.1017/s1092852900000833 · Cited by 24
Effects of physical activity on the symptoms of Tourette syndrome: A systematic review
Kim, D. D., Warburton, D. E. R., Wu, N., Barr, A. M., Honer, W. G., & Procyshyn, R. M. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.11.002 · Cited by 27
“Studies that examined cerebrospinal fluid biogenic amines further demonstrated elevated levels of norepinephrine in TS patients compared with healthy individuals [7].”
The role of neurotransmitters and neurohormones in obsessive-compulsive disorder
Greenberg, B. D., Altemus, M. M., & Murphy, D. L. (1997) · International Review of Psychiatry · doi:10.1080/09540269775574 · Cited by 25
Lustberg, D. J., Liu, J. Q., Iannitelli, A. F., Vanderhoof, S. O., Liles, L. C., McCann, K. E., & Weinshenker, D. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105205 · Cited by 21
Braun, C. M. J., Léveillé, C., & Guimond, A. (2008) · Cognitive Neuropsychiatry · doi:10.1080/13546800802088580 · Cited by 23
“The opposite profile has been observed, though marginally significantly, in OCD (Insel, Mueller, Alterman, Linnoila, & Murphy, 1985; Leckman et al., 1995).”
BackgroundPatterns of obsessive compulsive symptoms in tourette subjects are independent of severity
de Groot, C. M., Bornstein, R. A., Janus, M., & MAVISSAKALIAN, M. R. (1994) · Anxiety · doi:10.1002/anxi.3070010604 · Cited by 20
Eriguchi, Y., Kuwabara, H., Inai, A., Kawakubo, Y., Nishimura, F., Kakiuchi, C., Tochigi, M., Ohashi, J., Aoki, N., Kato, K., et al. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32559 · Cited by 18
“, 2000), noradrenergic (Leckman et al., 1995), serotonergic (Müller-Vahl et al.”
BackgroundCandidate Genes and Pathways Associated with Gilles de la Tourette Syndrome—Where Are We?
Levy, A. M., Paschou, P., & Tümer, Z. (2021) · Genes · doi:10.3390/genes12091321 · Cited by 19
“Interest in the serotonergic pathway in GTS etiology began when decreased levels of serotonin and 5-HIAA were detected in the cerebrospinal fluid and subcortical brain regions of GTS individuals [41–43], although these results could not be replicated in a later study [44].”
ResultLi, S., Wu, H., Liu, Y., Gu, H., & Yu, R. (2013) · Chinese Chemical Letters · doi:10.1016/j.cclet.2013.01.044 · Cited by 18
Vahabzadeh, A. B. N., & McDougle, C. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.05213-8 · Cited by 19
Self-citationSecondary Tics or Tourettism Associated With a Brain Tumor
Luat, A. F., Behen, M. E., Juhász, C., Sood, S., & Chugani, H. T. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.07.009 · Cited by 18
“Neurochemically, both dopaminergic [3,7,12] and serotonergic pathways [4,13-15] have been implicated in the pathophysiology of Tourette syndrome.”
BackgroundA neurobiological model for Tourette syndrome centered on the nucleus accumbens
Brito, G. N. O. (1997) · Medical Hypotheses · doi:10.1016/s0306-9877(97)90218-8 · Cited by 21
Barbarich, N. C. (2002) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03327460 · Cited by 18
Analysis of the dopamine beta hydroxylase gene in Gilles de la tourette syndrome
Ozbay, F., Wigg, K. G., Turanlı, E. T., Asherson, P. J., Yazgan, Y., Sandor, P., & Barr, C. L. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30393 · Cited by 16
“[1995] reported a significant elevation of cerebrospinal fluid norepinephrine levels in GTS patients compared to controls [Leckman et al., 1995].”
ResultOBSESSIVE-COMPULSIVE DISORDER AND TIC SYNDROMES
Swerdlow, N. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70338-2 · Cited by 17
Rasmusson, A. M., Anderson, G. M., Lynch, K. A., McSwiggan-Hardin, M., Scahill, L. D., Mazure, C. M., Goodman, W. K., Price, L. H., Cohen, D. J., & Leckman, J. F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00380-0 · Cited by 16
Self-citationBrambilla, F., Bellodi, L., Perna, G., Arancio, C., Bertani, A., Perini, G., Carraro, C., & Gava, F. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)03009-0 · Cited by 16
Metadata
- Authors
- Leckman, J. F., Goodman, W. K., Anderson, G. M., Riddle, M. A., Chappell, P. B., McSwiggan-Hardin, M. T., McDougle, C. J., Scahill, L. D., Ort, S. I., Pauls, D. L., Cohen, D. J., & Price, L. H.
- Affiliations
- Yale University (US)
- University of Florida Health (US)
- Yale New Haven Hospital (US)
- Johns Hopkins University (US)
- Augusta University (US)
- Corresponding author
- Leckman, James F
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 1995-02
- Volume
- 12
- Issue
- 1
- Pages
- 73-86
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2142890840
- Cited by
- 169
- References
- 87
- Citations by year
- 2026: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 8 · 2013: 9 · 2012: 4
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion, cc-by-nc-nd)
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh044843-03, MH30929, HD03008, MH49351, MH44843)
- National Institute of Mental Health (MH00508, MH49351, P01MH049351, MH 44843)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- cerebrospinal fluid, biogenic amines, obsessive-compulsive disorder, Tourette syndrome, noradrenergic system, dopaminergic system, serotonergic system, norepinephrine, tyrosine, homovanillic acid, MHPG, tryptophan, 5-hydroxyindoleacetic acid, pathobiology
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Biogenic Amines, Female, Tourette Syndrome, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.